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Abstract
 
Expulsion of the gastrointestinal nematode
 
 Trichuris muris
 
 is mediated by a T helper (Th) 2 type
response involving interleukin (IL)-4 and IL-13. Here we show that Th1 response–associated
susceptibility involves prior activation of IL-18 and caspase-1 followed by IL-12 and interferon
(IFN)-
 

 
 in the intestine. IL-18–deficient mice are highly resistant to chronic 
 
T. muris
 
 infection
and in vivo treatment of normal mice with recombinant (r)IL-18 suppresses IL-13 and IL-4 se-
cretion but does not affect IFN-
 

 
.
In vivo treatment of 
 
T. muris
 
–infected IFN-
 

 
–deficient mice with rIL-18 demonstrated that
the inhibitory effect of IL-18 on IL-13 secretion is independent of IFN-
 

 
. Hence, IL-18 does
not function as an IFN-
 

 
–inducing cytokine during chronic 
 
T. muris
 
 infection but rather as a
direct regulator of Th2 cytokines. These results provide the first demonstration of the critical
role of IL-18 in regulating Th cell responses during gastrointestinal nematode infection.
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Introduction
 
Gastrointestinal nematodes cause some of the most prevalent
and chronic human diseases worldwide. The human whip
 
worm (
 
Trichuris trichiura
 
) currently infects 
 

 
1 billion people
(1). The naturally occurring mouse counterpart 
 
Trichuris
muris
 
 has provided much information on the immunoregula-
tory mechanisms underlying resistance and susceptibility to
this parasite. Infection of inbred mouse strains with 
 
T. muris
 
results in expulsion of the worms and the development of re-
sistance in the majority of mouse strains (e.g., Balb/c and
Balb/K). However, certain strains of mice (e.g., AKR/J and
B10.BR) fail to expel this parasite and harbor chronic infec-
tions. A number of studies have shown that the ability to de-
velop resistance or chronicity is dependent on Th2 and Th1
cells, respectively (2–5). The Th cell response in mice that
develop resistance is dominated by secretion of IL-4, IL-5,
 
IL-9, and IL-13 in the mesenteric lymph node (MLN)
 
*
 
 tis-
sue and, conversely, the Th cell response in mice that de-
 
velop chronic infections is dominated by high levels of IFN-
 

 
secretion. Blocking Th2 response development in resistant
mice by disrupting the IL-4 gene, blockade of the IL-4 re-
ceptor, or administration of IL-12 abrogates resistance and
induces chronic infection (3–5). Furthermore, administration
of IL-4 to susceptible mice induces expulsion of worms (3).
IL-18, originally named IFN-
 

 
–inducing factor (6), is a
potent inducer of IFN-
 

 
, particularly when acting in con-
cert with IL-12 (6–9). It acts mainly on Th cells and NK
cells but has also been reported to stimulate B cells (10, 11)
and bone marrow–derived macrophages (12) to synthesize
IFN-
 

 
. IL-18 is mainly produced by monocytes/macro-
phages and dendritic cells but is also produced by other cell
types such as osteoblasts (13), keratinocytes, and cells in the
adrenal cortex (14). IL-18 is produced in an inactive form
that is cleaved by caspase-1 (ICE) to generate functionally
active IL-18 (15, 16), in a similar way to the processing of
IL-1
 

 
, a close relative in the IL-1 superfamily. IL-18
knockout (KO) mice display reduced IFN-
 

 
 production
and lower NK cell activity (17). IL-18 is also an important
cytokine in the induction of proinflammatory responses in
the gut and is upregulated in the intestinal mucosa of pa-
tients with inflammatory bowel disorders such as Crohn’s
disease (18, 19). Interestingly, some recent reports suggest a
role for IL-18 in promoting Th2 responses, such as in-
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creased levels of IgE, IL-4, and IL-13 after in vivo or
 
 
 
in
vitro stimulation with IL-18 (20, 21). Therefore, it appears
that IL-18 is a pleiotropic cytokine which may have differ-
ent roles in the immune response depending on where and
when it is induced.
In this report we provide new information on the cyto-
kine-mediated initiation of chronic gastrointestinal nema-
tode infection. We show that IL-18 mRNA and protein is
expressed in the colonic mucosa during Th1-mediated
chronic intestinal nematode infection. Furthermore, we
demonstrate that IL-18 KO mice are highly resistant to
chronic nematode infection and develop strong Ag-specific
Th2 responses. Administration of recombinant (r)IL-18 to
naturally resistant mice result in suppression of Ag-specific
secretion of IL-13 and IL-4 and the development of
chronic infection. Importantly, the levels of IFN-
 

 
 were
unaffected demonstrating that, rather than inducing IFN-
 

 
in chronic 
 
T. muris 
 
infection, IL-18 acts as a direct negative
regulator of Th2 cytokines such as IL-13 and/or IL-4. This
study provides, for the first time, conclusive evidence that
IL-18 plays a key pathogenic role in chronic gastrointesti-
nal nematode infections.
 
Materials and Methods
 
Animals and Infections.
 
6–8-wk-old male Balb/c, C57Bl/6,
and AKR mice were purchased from Harlan Olac Ltd. Mice in
which the IL-18 gene is disrupted (IL-18 KO mice) were as de-
scribed by Takeda et al. (17). IL-12 KO mice were provided by
Jeanne Magram (Hoffman-La Roche, Nutley, NJ; reference 22).
IFN-
 

 
 KO mice were originally purchased from Jackson Immu-
noResearch Laboratories and bred at the animal unit at The Uni-
versity of Manchester. All experiments were performed under the
regulations of the Home Office Scientific Procedures Act (1986).
 
T. muris
 
 was maintained as described by Bancroft et al. (5) and
experimental mice were infected by oral gavage on day 0, and the
numbers of larvae were counted on day 10 post infection (p.i.) to
ensure equivalent establishment of infection in the different
groups. 
 
T. muris
 
 excretory/secretory (ES) Ag was prepared as de-
tailed previously (5).
In vivo treatment with rIL-18 was performed by intraperito-
neal injections of 200 ng rIL-18 (Peprotech) per mouse daily
from days 4–17 after 
 
T. muris
 
 infection. Control mice received
intraperitoneal injections of PBS.
 
Cell Culture and Cytokine Analysis.
 
MLN cells were removed
from uninfected and infected animals and resuspended in RPMI
1640 supplemented with 10% heat-inactivated FCS, 2 mM 
 
L
 
-glu-
tamine, 100 U/ml penicillin, 100 
 

 
g/ml streptomycin, and
0.05 mM 
 

 
-mercaptoethanol (all from Life Technologies). MLNs
were cultured at 37
 

 
C and 5% CO
 
2
 
 in flat-bottomed 96-well
plates (Life Technologies) at a final concentration of 5 
 
 
 
10
 
6
 
 cells
per milliliter in a final volume of 0.2 milliliter per well. Cells
were stimulated with 50 
 

 
g/ml 
 
T. muris
 
 ES Ag, 1 
 

 
g/ml LPS
(Sigma-Aldrich), or varying doses of recombinant mouse IL-18
(Peprotech). Anti–IL-4 receptor mAb (5 
 

 
g/ml M1; from Dr. C.
Maliszewski, Immunex Corp., Seattle, WA) was added to cul-
tures to increase detection of IL-4. Cell-free supernatants were
harvested after 48 h and stored at
 
 
 
80
 

 
C.
 
Cytokine ELISA.
 
Cytokine analyses were carried out using
sandwich ELISAs for IL-4 (mAb BVC4-1D11 and BVD6-
24G2.3; BD PharMingen), IL-5 (TRFK-4 and TRFK-5; BD
PharMingen), IFN-
 

 
 (R46A2 and XMG1.2; BD PharMingen),
and IL-12p40 (C15.6 and C17.8; from Dr. G. Trinchieri, Scher-
ing-Plough, Dardilly, France). IL-13, IL-18, and IL-10 were ana-
lyzed using antibody pairs from R&D Systems.
 
Immunohistochemistry.
 
5-mm sections of caeca from infected
and uninfected mice were submerged in liquid nitrogen-cooled
OCT embedding compound (Sakura Finetechnical Co.) and
stored at 
 

 
80
 

 
C until processed. 5-micron cryostat sections were
placed on glass slides and fixed in 3.7% PBS-buffered paraformal-
dehyde for 15 min at 4
 

 
C, washed three times in PBS, and blocked
with 10% pig serum in 1% BSA/PBS for 1 h at room temperature.
The sections were then incubated with 10 
 

 
g/ml of rabbit-anti–
mouse IL-18 antibody (Peprotech) or control rabbit IgG (Sigma-
Aldrich) for 1 h, washed in PBS three times, and blocked for en-
dogenous peroxidase with MeOH/0.3% H
 
2
 
O
 
2
 
/0.1% NaN
 
3
 
 for 30
min. Bound antibody was detected by incubation with horseradish
peroxidase–conjugated swine-anti–rabbit Ig (Dako) followed by
3.3
 

 
-diaminobenzidine (Dako) as substrate. The slides were briefly
counterstained with Mayers Haemalum (BDH), dehydrated into
citroclear, and mounted in DePeX (BDH).
 
RNase Protection Assay.
 
Total RNA was extracted from tissue
specimens taken from the caecal tip using Trizol (Life Technolo-
gies) according to the manufacturer’s instructions. A custom-
made Riboquant template (BD PharMingen) was used to assay
mRNA levels of IL-12, IL-18, IFN-
 

 
, caspase-1, and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH). An IL-18R
 
	
 
 tem-
plate was constructed by PCR cloning an IL-18R
 
	
 
 cDNA frag-
ment (11) into pGEM-T Easy Vector (Promega). A clone with
the correct insert was confirmed by sequencing (data not shown)
and the plasmid purified by ethidium bromide centrifugation and
linearized. In vitro transcription with 
 
32
 
[P]-labeled UTP (Amer-
sham Pharmacia Biotech) was performed using a Riboprobe kit
(Promega) and SP6 (IL-18R
 
	
 
) or T7 (IL-12, IL-18, IFN-
 

 
,
caspase-1, and GAPDH) polymerase (Promega). 10 
 

 
g of RNA
from each sample was hybridized with the radiolabeled antisense
RNA probe set, digested with RNAses, purified, and the pro-
tected probes were resolved on denaturing sequencing gels. Dried
gels were exposed to phosphorimaging screens and protected
fragments visualized using a Molecular Imager FX System (Bio-
Rad Laboratories). All samples were normalized in respect to the
housekeeping gene GAPDH to ensure equal input of RNA.
 
Statistics.
 
Significant differences (
 
P 
 

 
 
0.05) between experi-
mental groups were determined using the Mann-Whitney U test.
 
Results
 
IL-18 mRNA Expression Is Rapidly Upregulated in the
Large Intestine During Chronic T. Muris Infection.
 
To inves-
tigate the kinetics of the proinflammatory response at the
site of infection in mice with chronic 
 
T. muris
 
 infection
compared with resistant animals, we analyzed the cytokine
mRNA levels in the large intestine by RNase protection
assay (RPA). Susceptible AKR mice already show in-
creased expression of IL-18 mRNA on days 8 and 12 p.i.
(Fig. 1 A). Thereafter, IL-18 mRNA expression declined
to baseline levels. Interestingly, the level of IL-12p40
mRNA displayed a different pattern of kinetics and the
peak of expression was later (day 16 p.i.) than the peak of
IL-18 mRNA (Fig. 1, A and B). Furthermore, IFN-
 

 
 ex-
pression did not reach a peak until day 20 p.i. (Fig. 1 C).
The mRNA levels of these proinflammatory cytokines
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were only expressed at low levels during the course of in-
fection in the large intestine of resistant Balb/c mice (Fig.
1, A–C). These results indicate that IL-18 is an early in-
ducer of the intestinal Th1 response in 
 
T. muris
 
–susceptible
animals. In addition, elevated intestinal expression of IL-18
mRNA precedes the upregulation of IL-12 and IFN-
 

 
mRNA during chronic 
 
T. muris
 
 infection.
 
Caspase-1 and IL-18R
 
	
 
 mRNA Expression Is Increased in
the Large Intestine During Chronic T. Muris Infection.
 
Since
IL-18 is cleaved to the bioactive form by caspase-1 we in-
vestigated whether caspase-1 mRNA was upregulated in
the large intestine of susceptible mice during 
 
T. muris
 
 infec-
tion. As shown in Fig. 2 A, an increase in caspase-1
mRNA could be seen coincidently with the upregulation
of IL-18 mRNA at early timepoints (days 8 and 12 p.i.;
Fig. 1 A) suggesting that IL-18 is indeed cleaved to a bioac-
tive form in the large intestine. We also investigated the in-
testinal expression of IL-18R
 
	
 
 chain and found an increase
in mRNA expression with a peak at day 20 p.i. (Fig. 2 B).
 
IL-18 Protein Is Expressed in the Lamina Propria of the Large
Intestine During T. Muris Infection.
 
The cellular source of
IL-18 protein at the site of infection was investigated by im-
munohistochemistry. Sections of large intestine from naive
and day 18 infected AKR mice were stained with anti–IL-
18 antibody and examined. Large intestine from naive mice
showed weak IL-18 staining in the lamina propria (Fig. 3 B),
while day 18 infected animals showed strong IL-18 staining
(Fig. 3 D). This finding demonstrates that IL-18 protein se-
cretion is still active despite the fact that IL-18 mRNA is al-
ready decreased in the large intestine (Fig. 1 A). The time of
IL-18 protein expression also correlates with IL-18R
 
	
 
mRNA expression (Fig. 2 B) suggesting that the IL-18 de-
tected expresses functional signaling capacity. The IL-18
staining of large intestine was confined to the lamina propria
with very strong staining of large elongated mononuclear
cells, which were likely to be macrophages or dendritic cells.
No staining could be detected within the epithelium.
 
IL-18 KO Mice Are Resistant to Chronic T. Muris Infec-
tion.
 
To evaluate the functional importance of IL-18
compared with IL-12 in the development of chronic gas-
trointestinal nematode infection, we infected IL-18 KO
and IL-12 KO mice with 
 
T. muris
 
. The IL-18 KO and IL-
12 KO mice were on a C57Bl/6 background and this strain
is usually resistant to high-dose infection (5). Therefore, we
utilized a low dose infection protocol enabling us to estab-
lish chronic infection in these C57Bl/6 mice (23). IL-18
KO, IL-12 KO, and C57Bl/6 wild-type (WT) mice were
infected with 25 embryonated 
 
T. muris
 
 eggs, and worm
burdens were assessed at days 10, 18, and 35 p.i. WT mice
developed chronic infection with full worm burdens at day
Figure 1. IL-18 is expressed earlier than IL-12 and IFN- in large intestine during chronic T. muris infection. mRNA for (A) IL-18, (B) IL-12p40,
and (C) IFN- in the large intestine of susceptible AKR mice (black bar) and resistant Balb/c (white bar) mice was measured by RPA at various time-
points during T. muris infection. mRNA were normalized with respect to the housekeeping gene GAPDH. Results are expressed as fold induction over
naive controls and values represent the mean value of 3–5 animals per group  SEM. *Significantly different between AKR and Balb/c. P 
 0.05.
Figure 2. Caspase-1 and IL-18R	 mRNA is ex-
pressed in large intestine during chronic T. muris infec-
tion. mRNA for (A) caspase-1 and (B) IL-18R	 in the
large intestine of susceptible AKR mice (black bar) and
resistant Balb/c (white bar) mice was measured by
RPA at various timepoints during T. muris infection.
mRNA were normalized with respect to the house-
keeping gene GAPDH. Results are expressed as fold
induction over naive controls and values represent the
mean value of 3–5 animals per group  SEM. *Signifi-
cantly different between AKR and Balb/c. P 
 0.05.
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35 p.i. (Fig. 4). Interestingly, the IL-18 KO mice had al-
ready started to expel the worms at day 18 p.i. (P 
 0.01)
and had completed expulsion by day 35 p.i. (P 
 0.01),
clearly showing that IL-18 is critical in the induction of
chronic gastrointestinal nematode infection. Moreover, IL-
12 KO mice infected in the same experiment were also re-
sistant to infection, albeit with a slower expulsion speed
than the IL-18 KO mice (Fig. 4, not significant on day 18
p.i. but P 
 0.05 on day 35 p.i.), showing that IL-12 is also
an important component in chronic T. muris infection in
agreement with previously published results (4).
IL-18 KO Mice Secrete High Levels of both Th1 and Th2
Cytokines During T. Muris Infection. To investigate the ba-
sis for the difference between IL-12 and IL-18 KO mice, we
investigated the cytokine profiles from in vitro–stimulated
MLN cultures. The results in Fig. 4 B show that IL-18 KO
mice secrete similar amounts of Ag-specific IFN- to WT
mice at day 18 p.i. (IL-18 KO, 39.8  0.98 ng/ml; and
WT, 41.9  1.03 ng/ml). The IL-12 KO mice however,
secreted twofold lower levels of IFN- than both the IL-18
KO and WT mice (IL-12 KO, 23.2  5.42 ng/ml, P 

0.01 as compared with both IL-18 KO and WT at day 18
p.i.; Fig. 4 B). Interestingly, both IL-18 KO and IL-12 KO
mice secreted significantly higher levels of IL-4 than the WT
mice at day 18 p.i. (IL-18 KO, 140.9  31.8 pg/ml; IL-12
KO, 147.0  27.5 pg/ml; WT, 33.5  2.7 pg/ml, P 
 0.01
for both IL-18 KO and IL-12 KO mice as compared with
WT at day 18 p.i.; Fig. 4 C). This is despite the fact that
only the IL-18 KO mice had started worm expulsion at this
timepoint (Fig. 4 A) indicating that the IL-4 secreted in the
IL-12 KO mice was not sufficient to induce expulsion at a
similar rate as compared with the IL-18 KO mice.
As immune-mediated expulsion of T. muris is IL-13 de-
pendent (5), we analyzed the levels of IL-13 in the super-
natants to investigate if the difference in expulsion kinetics
between IL-18 KO and IL-12 KO mice was dependent on
IL-13 rather than IL-4. IL-18 KO mice secreted signifi-
cantly higher levels of Ag-specific IL-13 in the culture su-
pernatants than the IL-12 KO mice (IL-18 KO, 15 ng/
ml; IL-12 KO, 7.6  1.9 ng/ml; WT, 1.9  0.7 ng/ml,
P 
 0.05 for IL-18 KO versus IL-12 KO, not significant for
IL-12 KO versus WT; Fig. 4 D) suggesting that the slower
worm expulsion seen in the IL-12 KO mice was due to
lower secretion of IL-13 rather than IL-4.
MLN Cultures from T. Muris–infected IL-12 KO Mice Se-
crete High Levels of IL-18. Production of IL-18 and IL-12
protein is readily induced by LPS stimulation of macrophages
and/or dendritic cells (6, 24–27). To investigate any differ-
ences in the levels of IL-12 and IL-18 secretion between
the groups, the supernatants from LPS-stimulated MLN cul-
tures were analyzed. IL-18 KO mice secreted a threefold
lower amount of IL-12 in response to LPS stimulation at day
18 p.i. compared with WT mice (IL-12 KO, undetectable;
IL-18 KO, 613.5  103.8 pg/ml, WT, 1971.5  355.3 pg/
ml, P 
 0.01 for IL-18 KO versus WT; Fig. 4 E), while cul-
tures from IL-12 KO mice produced significantly more IL-
Figure 3. IL-18 is expressed in the
lamina propria of T. muris–infected
large intestine. Cryosections of large
intestine from naive (A and B) or
day 18 infected (C and D) AKR
mice were stained with rabbit anti–
IL-18 antibody (B and D) or control
rabbit IgG (A and C). Arrows indi-
cate worms in the day 18 infected
animals. A–D, original magnifica-
tion: 400.
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18 in response to LPS at both day 0 and day 18 p.i. (day 0;
IL-12 KO, 98.5  7.2 pg/ml; WT, 74.3  6.2 pg/ml, day
18; IL-12 KO, 102.4  3.4 pg/ml, WT, 85.5  6.0 pg/ml,
IL-18 KO, undetectable at all timepoints, P 
 0.05 for IL-12
KO versus WT at both timepoints) (Fig. 4 F).
In Vitro Treatment with Exogenous rIL-18 Inhibits Ag-spe-
cific IL-13 Secretion in MLN Cultures in the Absence of IL-12
or IFN-. To investigate if IL-18 regulates the secretion
of IL-13 and may be responsible for the reduced levels of
IL-13 seen in IL-12 KO mice, we restimulated MLN cells
Figure 4. IL-18 KO mice secrete high levels of IL-4 and IL-13 and are resistant to chronic T. muris infection. (A) Worm burdens from T. muris–
infected IL-18 KO (striped bar), IL-12p40 KO (white bar), and C57Bl/6 WT (black bar) mice were assessed at days 10, 18, and 35 p.i. MLN cells were re-
moved at day 0 (naive) and day 18 p.i. and stimulated in vitro with T. muris Ag (B–D) or LPS (E and F). Supernatants were analyzed by sandwich ELISA
for the presence of (B) IFN-, (C) IL-4, (D) IL-13, (E) IL-12p40, and (F) IL-18. Results represent the mean value of 5–7 mice per group  SEM. *Sig-
nificantly different from WT. P 
 0.05. **Significantly different from other KO. P 
 0.05. nd, not detectable.
Figure 5. In vitro treatment with exogenous rIL-18 inhibits Ag-induced IL-13 secre-
tion in MLN cultures from T. muris–infected IL-12 and IFN- KO mice. MLN cells from
day 18 T. muris–infected IL-12p40 KO mice (A) and IFN- KO mice (B) were stimulated
with T. muris Ag plus indicated doses of rIL-18 in vitro and the supernatant analyzed for
IL-13, IL-4, IL-5, IL-10, and IFN- secretion by sandwich ELISA. Results represent the
mean value of 5–7 mice per group  SEM. *Significantly different from cultures stimu-
lated with T. muris Ag only. P 
 0.05. 
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from infected IL-12 KO mice with Ag plus different doses
of rIL-18. Addition of rIL-18 to the Ag-stimulated cultures
reduced the levels of IL-13 secretion in a dose-dependent
manner (P 
 0.05 for Ag plus 2 ng/ml rIL-18 versus Ag
alone; Fig. 5 A). The addition of rIL-18 to the Ag-stimu-
lated cultures had no significant effect on IL-4, IL-5, IL-10,
or IFN- secretion. Furthermore, to investigate if the
downregulatory effect of IL-18 on IL-13 was IFN- inde-
pendent we used MLN cells from T. muris–infected IFN-
KO mice. Addition of rIL-18 to the Ag-stimulated cultures
again significantly downregulated IL-13 secretion (P 

0.05 for Ag plus 0.2 or 2 ng/ml rIL-18 versus Ag alone;
Fig. 5 B) while having no effect on IL-5 and IL-10 secre-
tion and a moderate effect on IL-4 secretion. These results
demonstrate that IL-18 can specifically inhibit the secretion
of IL-13 from already polarized Th2 cells in an Ag-specific
manner and that this inhibitory effect is independent of
both IL-12 and IFN-.
In Vivo Treatment of Naturally Resistant Mice with rIL-18
Leads to the Development of Chronic T. Muris Infection and
Suppression of Th2 Responses while Th1 Responses Remains
Unaffected. To investigate the effects of IL-18 in vivo,
C57Bl/6 mice that are naturally resistant to high dose T.
muris infection (5) were treated with daily injections of rIL-
18 (200 ng per mouse from days 4–17 p.i.). Control mice
that received PBS injections expelled the parasites from the
intestine in normal resistant fashion (Fig. 6 A). Mice treated
with rIL-18, however, were unable to expel the worms
and developed chronic infections (Fig. 6 A). Restimulation
of MLN cells with Ag revealed that the in vivo treatment
with rIL-18 did not augment Ag-specific IFN- secretion
(Fig. 6 B) and that the levels of IL-12 were unaffected (Fig.
6 E). However, rIL-18 treatment significantly suppressed
Ag-specific IL-4 (PBS treated 181.8  87.4 pg/ml, rIL-18
treated 84.1  23.0 pg/ml, P 
 0.05) and IL-13 secretion
(PBS treated 2.78  0.73 ng/ml, rIL-18 treated 0.44 
Figure 6. In vivo treatment
with rIL-18 induces chronic T.
muris infection without increas-
ing Th1 responses. T. muris–
infected C57Bl/6 mice were in-
jected with rIL-18 (white bar) or
PBS (black bar) daily for 14 d.
(A) Worm burdens were as-
sessed at days 10, 18, and 35 p.i.
MLN cells were removed at day
0 (naive) and day 18 p.i. and
stimulated in vitro with T. muris
Ag (B–D) or LPS (E and F). Su-
pernatants were analyzed by
sandwich ELISA for the presence
of (B) IFN-, (C) IL-4, (D) IL-
13, (E) IL-12p40, and (F) IL-18.
Results represent the mean value
of 5–7 mice per group  SEM.
*Significantly different from
PBS-treated control (P 
 0.05). 
Figure 7. In vivo treatment with
rIL-18 delays worm expulsion and
suppresses Ag-specific IL-13 secre-
tion independently of IFN-. T.
muris–infected IFN- KO mice
were injected with rIL-18 (white
bar) or PBS (black bar) daily for 14 d.
(A) Worm burdens were assessed at
day 18 p.i. and MLN cells were
stimulated in vitro with T. muris Ag
(B and C) or LPS (D and E). Super-
natants were analyzed by sandwich
ELISA for the presence of (B) IL-4,
(C) IL-13, (D) IL-12p40, and (E)
IL-18. Results represent the mean
value of 4–5 mice per group 
SEM. *Significantly different from
PBS-treated control. P 
 0.05.
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0.16 ng/ml, P 
 0.05) (Fig. 6, C and D), clearly demon-
strating that IL-18 inhibits T. muris–specific Th2 responses
in vivo without augmenting Th1 responses.
The Inhibitory Effect of IL-18 on IL-13 Secretion Is Indepen-
dent of IFN- In Vivo. To confirm that the IFN-–inde-
pendent effects of IL-18 seen in vitro (Fig. 5) also extended
to an in vivo situation, we treated T. muris–infected IFN-
KO mice with daily injections of rIL-18 (200 ng per mouse
from day 4–17 p.i). Worm burdens were assessed at day 18
p.i. and found to be significantly higher in the rIL-18–
treated animals demonstrating that IL-18 significantly af-
fects worm expulsion in vivo in the absence of IFN- (Fig.
7 A). Restimulation of MLN cells with Ag demonstrated
that the in vivo treatment with rIL-18 did not affect IL-4
or IL-12p40 secretion (Fig.7, B and D) but significantly en-
hanced IL-18 secretion (PBS treated 55.83  8.67 pg/ml,
rIL-18 treated 177.27  28.98 pg/ml, P 
 0.05; Fig. 7 E).
Importantly, the in vivo treatment suppressed Ag-specific
IL-13 secretion (PBS treated 17.96  1.85 ng/ml, rIL-18
treated 4.34  0.95 ng/ml, P 
 0.05; Fig. 7 C), confirm-
ing that IL-18 inhibits T. muris–specific IL-13 responses in
vivo independently of IFN-.
Discussion
The data presented in this report provide the first dem-
onstration that the proinflammatory cytokine IL-18 is a
crucial component in the development of chronic gas-
trointestinal infection. Furthermore, we demonstrate that
the effects of IL-18 during T. muris infection of the intes-
tine is mediated through its immunomodulatory effects on
Th2 cytokines, most notably IL-13, rather than its ability to
induce IFN- responses.
Immune-mediated expulsion of T. muris from infected
mice is clearly dependent on a Th2 type of response in-
volving IL-4 and IL-13 (3, 5). However, certain strains of
mice are unable to expel the worms and develop chronic
infections. This susceptibility is associated with a Th1 type
of response but little is known of the events leading up to
the initiation of the IFN- response in these mice. Impor-
tantly, treatment with rIL-12 induces chronic T. muris
infection in mouse strains that are normally resistant, dem-
onstrating that IL-12 plays an important role in the de-
velopment of chronic infection (4).
IL-18 is an important component in the development of
a Th1 response. However, IL-18 alone is unable to initiate
a Th1 response and requires the presence of IL-12 in order
to do so (6–8). In our experiments, quantitative RNase
protection analysis of intestinal mRNA expression in T.
muris–infected mice revealed that upregulation of IL-18
mRNA at the site of infection occurred earlier than IL-12
mRNA expression in mice that develop chronic infection.
This was an unexpected finding since it has previously been
reported that IL-12 induces IL-18 and IL-18R expression
(7, 11, 28). However, our data suggest that upregulation of
intestinal IL-18 mRNA can be independent of IL-12 and
provides the first demonstration of this event during an in
vivo infection. Furthermore, the coincident expression of
the IL-18–activating enzyme caspase-1 mRNA during the
early timepoints of infection suggests that a separate proin-
flammatory pathway to that of IL-12 was induced in the
intestine. The later upregulation of IL-12 mRNA expres-
sion correlated with the increased expression of IL-18R	
mRNA which is consistent with the observation that IL-12
upregulates IL-18R expression (7, 11, 28). IL-12R (both
1 and 2 subunits) mRNA was also upregulated in the
intestine of susceptible mice over a similar time frame to
that of IL-12 mRNA (data not shown). This indicates that
chronic T. muris infection upregulates the signaling path-
way for IL-12 at the site of infection in a similar manner to
that seen after infection with the parasitic protozoa Leish-
mania major (29, 30).
Immunohistological analysis demonstrated that IL-18
protein is constitutively produced at low levels in the large
intestine of naive mice. However, IL-18 protein was
greatly increased during T. muris infection in susceptible
mice in a similar fashion to that observed in human large
intestine during Crohn’s disease (18, 19). The IL-18 stain-
ing was confined to the lamina propria with no staining of
the epithelium. This is interesting bearing in mind recent
work suggesting that epithelial cell lines are able to produce
IL-18 (31).
To investigate the functional roles of IL-18 and IL-12 in
this infection model we infected IL-18 KO, IL-12 KO, and
WT (C57Bl/6) mice with T. muris. By using a low dose
protocol it is possible to induce chronic infection in mice
that are normally resistant, such as C57Bl/6 (23). We suc-
cessfully established chronic infections in C57Bl/6 WT
mice and, consistent with a susceptible phenotype, these
mice had high IFN- and low IL-4 and IL-13 responses in
the MLNs. Interestingly, the IL-18 KO (C57Bl/6) mice
rapidly expelled the worms. There was already a significant
decrease in worm burden by day 18 p.i. in IL-18 KO mice
and almost complete expulsion by day 35 p.i. The IL-12
KO mice infected in the same experiment showed delayed
expulsion compared with IL-18 KO mice and had only
partially expelled their worm burden by day 35 p.i., a time
at which IL-18 KO mice had already completed the pro-
cess. These results demonstrate that IL-18 is critical for the
induction of chronic gastrointestinal nematode infection
and that in the absence of IL-12 alone, expulsion takes
place but with slower kinetics. One possible explanation
for these observations may be related to the increased levels
of IL-18 detected in the IL-12 KO mice.
Both IL-12 KO and IL-18 KO mice have previously
been shown to display defective Th1 responses in response
to various Ags (17, 22). Indeed, IL-12/IL-18 double KO
mice show almost undetectable Th1 responses (17), dem-
onstrating the important synergistic effects of these cyto-
kines in the induction of most Th1 type responses. Inter-
estingly, cytokine analysis of Ag-stimulated MLN cultures
(the lymph nodes that drain the large intestine) from T.
muris–infected IL-18 KO mice showed that in the absence
of IL-18, the IFN- response on day 18 p.i. was equivalent
to that seen in WT mice. However, in IL-12 KO mice
there was a marked reduction in IFN- production despite
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increased secretion of IL-18, demonstrating that IL-12
alone is sufficient for the induction of IFN- in this system.
However, it is notable that the high IFN- secretion in IL-
18 KO mice and the low levels of IFN- seen in IL-12 KO
mice did not reflect the speed of expulsion. Importantly,
these results demonstrate that worm expulsion can take
place even in the presence of high levels of IFN-. Experi-
ments in IL-18 KO mice using another parasite, the para-
sitic protozoa L. major, show conflicting results. In some
studies, IL-18 KO mice have reduced IFN- secretion (32)
while in other studies no differences were seen (33, 34).
Possible reasons for these different results may include vari-
ations in the genetic background of the mouse strains stud-
ied or strains of L. major parasites used. Taken together
with our data it appears that the IFN-–inducing ability of
IL-18 may depend on the disease, the genetic background
of the host, and/or site of infection.
To investigate the basis for the observed differences in
kinetics of worm expulsion between WT, IL-12 KO, and
IL-18 KO mice, we analyzed the levels of IL-4 and IL-13
protein in the supernatants from Ag-stimulated MLN cul-
tures. The rapid worm expulsion seen in IL-18 KO mice
correlated well with high levels of both IL-4 and IL-13 in
the MLN supernatants. The IL-12 KO mice however,
which suffered from a slower expulsion rate, had high lev-
els of IL-4 but significantly lower levels of IL-13. Since IL-
13 is a crucial mediator of T. muris expulsion (5) it is likely
that the low levels of IL-13 detected in the IL-12 KO mice
are responsible for the slow expulsion rate in these mice.
Interestingly, the IL-12 KO mice also had increased levels
of IL-18 secretion compared with WT mice. Significantly,
when MLN cells from these mice were restimulated with
Ag plus exogenous rIL-18 the low levels of secreted IL-13
were decreased further. This effect appears to be IL-13–
specific since there was no effect on the secretion of other
Th2 cytokines such as IL-4, IL-5, and IL-10 or on the se-
cretion of the Th1 cytokine IFN-. The addition of rIL-12
to the cultures had no such effect (data not shown). Impor-
tantly, this downregulatory effect of IL-18 on IL-13 was
also observed when MLN cells from IFN- KO mice were
used demonstrating that this effect is IFN- independent.
This demonstrates for the first time that IL-18 can directly
inhibit IL-13 secretion in an Ag-specific system even when
Th2 cells are already polarized in vivo.
To confirm the direct effects of IL-18 on the develop-
ment of Th2 responses in vivo we treated C57Bl/6 mice
with rIL-18 during the course of a high dose T. muris in-
fection. This mouse strain is resistant to high dose infection
and will under normal conditions expel the worms within
35 days p.i. (5). However, the animals that received rIL-18
treatment (200 ng/day) from days 4–17 during infection
did not expel the worms and developed chronic infections
unlike the PBS-treated controls which all became resistant
and expelled the parasites. Importantly, cytokine analysis
showed that in vivo treatment with rIL-18 did not aug-
ment IFN- or IL-12 secretion from restimulated MLN
cells but significantly reduced both IL-4 and IL-13 secre-
tion. When the same experiment was performed in IFN-
KO mice a similar delay in worm expulsion and decrease in
IL-13 secretion could be seen proving that the effects of
IL-18 on worm expulsion and IL-13 secretion is indepen-
dent of IFN- in vivo. These results clearly confirm that
the proinflammatory effects of IL-18 during an intestinal
nematode infection such as T. muris is not mediated by
augmentation of Th1 responses but as a negative regulator
of Th2 cytokine secretion.
Previously published work has shown that IL-18 pro-
motes IFN- responses in Th1 cells but does not affect IL-4
production from Th2 cells (8, 9, 35). Some interesting
recent observations indicate a role for IL-18 in promoting
Th2 responses both in vivo or in vitro by increasing levels
of IgE, IL-4, and IL-13 (20, 21). However, it is notewor-
thy that very high doses of IL-18 are needed to induce
these Th2 type responses (20, 21) and a possible explana-
tion may be that the inhibitory or stimulatory effects of IL-
18 on Th2 cells are dose dependent in a similar fashion to
that seen with other cytokines such as TGF- (36, 37).
However, in our experiments, both in vivo and in vitro,
we were unable to find any correlation between IL-18 and
increased Th2 responses to T. muris infection. There may
be other factors that influence these opposing effects of IL-
18 including the type of Ag and the dose as well as the site
of the immune response. Further experiments are required
to clarify the roles of IL-18 in the negative and positive
regulation of Th2 cytokine production.
The data presented in this paper provides new informa-
tion on the cytokine-mediated initiation of chronic T.
muris infection. Importantly, the results demonstrate that
IL-18, instead of functioning as an IFN- inducer in
chronic T. muris infection, act as a direct regulator of Th2
cytokines such as IL-13 and/or IL-4. In summary, our
studies provide conclusive evidence that IL-18 plays a key
pathogenic role in chronic gastrointestinal nematode in-
fections and that IL-18 may have a key regulatory role that
is independent of IL-12 and/or IFN-. This is the first re-
port showing the importance of IL-18 during parasitic hel-
minth infection and these results extend our knowledge
on the cytokine-mediated regulation of intestinal inflam-
mation and may provide important information for the
design of rational therapies against helminth infection, al-
lergic reactions, and inflammation of the gut and other
mucosal sites.
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